Valley surgeon heads up test of aneurysm treatment - Business First of Louisville:

Amana PBC092B00MB
Rodriguez, the director of peripheral vasculart services at the ArizonaHeart Institute, has been named the nationalp principal investigator for the Phase II study, which is requiredc by the to enroll 160 patients. The Arizona Heartt Institute is one of 14 centers involves in thestudy nationwide. “We are looking to include at leasyt six more centers to complete 20 centers inthe U.S.,” Rodriguez said. The endoluminal graftt is manufactured bynear Glasgow, Scotland.
Called the Anacondas Stent Graft System, it allows the surgeom to reposition the device once it has been placed across the So far, nearly 4,000 patients in Europee have received the Anacond device, but it must get approval from the FDA before it can be used in the U.S. Rodriguex said the minimally invasive procedure onthe study’s first patientt went well, saying the device is very easy to use. “He was up on his feet the next morninghaving breakfast,” Rodriguez said of the “You can’t do that when you open the chest. This eliminatee the need for openheart surgery.
” Abdominal aortid aneurysm, or “ballooning” of the body’s main is a serious condition prone to rupture and lead to suddenj death. Actor John Ritter died of an aortiv rupturein 2003. Symptoms can occur suddenly with severe, sharp pain in the Patients who experience these symptoms should seek immediatedmedical attention, Rodriguez said. Early detectionn can prevent sudden death. Patients with a family history of aortif aneurysm or other connective tissue disorderxs should notify their physician about their risk ofaortifc aneurysm, he said.